Track Novozymes A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Novozymes A/S NSIS-B.CO Open Novozymes A/S in new tab

378.20 DKK
P/E
39.52
EPS
9.57
Yield
1.63%
Safety Score
67
P/B
2.15
ROE
5.39
Beta
0.63
Target Price
461.41 DKK
Novozymes A/S logo

Novozymes A/S

🧾 Earnings Recap – Q1 2026

Novonesis shares declined 2.7% following Q1 results that showed margin pressure in key divisions and cautious volume-driven growth amid headwinds, falling short of fully reassuring investors despite stable guidance.

  • Organic sales grew 7% overall, including a 1.5 percentage point drag from exiting certain countries and a 1 point boost from inventory buildup in Animal.
  • Adjusted EBITDA margin was 37.8%, slightly below the maintained full-year guidance range of 37–38%, indicating margin compression primarily from product mix shifts and currency impact.
  • Food & Health Biosolutions grew 9% organically but saw a 130 basis point margin decline driven by commercial ramp-up, unfavorable product mix (notably HMO), and currency headwinds.
  • Food & Beverages posted 11% volume-driven organic growth with pricing contributing ~1 point; growth was broad-based but reliant on innovation adoption amid muted consumer sentiment.
  • Human Health advanced 5% organically, challenged by softness in North American dietary supplements but supported by strong early life nutrition and Advanced Health & Nutrition products.
📅
Loading chart...
Key Metrics
Earnings dateAug. 20, 2026
P/E39.52
EPS9.57
Book Value176.20
Price to Book2.15
Debt/Equity29.42
% Insiders15.806%
Growth
Revenue Growth0.04%
Earnings Growth0.08%
Estimates
Forward P/E21.65
Forward EPS17.47
Target Mean Price461.41
Dividend
Dividend Yield1.63%
Annual dividends0.87 DKK
Ex-Div. DateMarch 24, 2026
Payout68.92%
5y avg Yield1.48%

DCF Valuation

Tweak assumptions to recompute fair value for Novozymes A/S (NSIS-B.CO)
Currency: DKK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Novozymes A/S Logo Novozymes A/S Analysis (NSIS-B.CO)

Denmark Basic Materials Official Website Stock

Is Novozymes A/S a good investment? Novozymes A/S (NSIS-B.CO) is currently trading at 378.20 DKK. Market analysts have a consensus price target of 461.41 DKK. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 39.52. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Novozymes A/S is expected to release its next earnings report on Aug. 20, 2026. The market consensus estimate for Forward EPS is 17.47.

For income investors, Novozymes A/S pays a dividend yield of 1.63%. With a payout ratio of 69%, the dividend appears sustainable.

Investor FAQ

Does Novozymes A/S pay a dividend?

Yes, it pays an annual dividend of 0.87 DKK (1.63% yield).

What asset class is Novozymes A/S?

Novozymes A/S is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 20, 2026. The company currently has a trailing EPS of 9.57.

Company Profile

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.

Dividend Yield

1.63% (5y avg: 1.48%)

Annual Dividends

0.87 DKK

Next ex. div date

March 24, 2026

Payout Ratio

68.92%

Historical Dividends
Year Total Dividends
2027 4.54 DKK
2026 6.50 DKK
2025 6.45 DKK
2024 4.00 DKK
2023 10.20 DKK
2022 5.50 DKK
2021 5.25 DKK
2020 5.25 DKK
2019 5.00 DKK
2018 4.50 DKK
2017 4.00 DKK
2016 3.50 DKK
2015 3.00 DKK
2014 2.50 DKK
2013 2.20 DKK
2012 1.90 DKK
2011 8.00 DKK
2010 5.75 DKK
2009 5.25 DKK
2008 5.00 DKK
2007 4.50 DKK
2006 4.00 DKK
2005 3.50 DKK
2004 3.15 DKK
2003 2.25 DKK
2002 2.00 DKK
2001 1.65 DKK

Yearly aggregated dividends

Dividends

Novozymes A/S
Mar 26, 2026 Paid
Dividend
4.25 DKK
Novozymes A/S
Aug 27, 2025 Paid
Dividend
2.25 DKK

Historical Split Corporate Actions

Split Date Split Ratio to 1
Nov. 28, 2011 5.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion